At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Intravenous Lidocaine for Postoperative Recovery in Liver Surgery, a Randomized Double Blinded Placebo-controlled Study
In Brief
A Phase 3 clinical trial evaluating Lidocaine and Normal saline for Liver Metastases and 3 related conditions. Completed, enrolled 124 participants across 1 site.
Detailed Summary
This is a randomized double blinded placebo-controlled study, conducted in Lund, Sweden. Patients will be randomized in two groups, with a ratio of 1:1. The experimental arm will receive intravenous Lidocaine perioperatively, and the Control arm will receive placebo, i.e. normal Saline. Postoperative both arms will get routine pain Control with PCA, Patient Controlled Analgesia with an intravenous Oxycodone-infusion. Outcome-measures will include patients pain intensity scoring, and opioid consumption.
Study Details
Timeline
Interventions
Intravenous perioperative Lidocain for pain Control and improvement of postoperative recovery
Placebo